(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Inc. (Nasdaq: ELGX ), developer of minimally ... Dan Lemaitre, former President and CEO of CoreValve, ... December 11, 2009. Endologix now has four ... D. Brown, Chairman of the Board, said, "We ... Endologix Board of Directors. He has a ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... growing developer and,producer of prescription drugs and ... People,s Republic of China ("PRC"), today reported ... controlled operating entity of Lotus,appointed Mr. Jinzhong ... Company,s,Over-the-Counter Drug division ("OTC Division"). , ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3... , , ... , , , , ... protein from human melanoma cell lines [1]. MIA,is expressed in and ... chondrocytes,is dependent on the differentiation status of the cells,it was also ...
... , , , ... , Abstract , ... The efficiency of the Rapid DNA Ligation Kit from,Roche Molecular ... DNA in a three-fragment assembly,DNA ligation. Sequential blunt-end and cohesive-end,ligation, including a temperature ...
... , ... , , Roche Applied Science was ... move away from the use of hazardous,radioactive isotopes. Even after 15 ... technologies, the,DIG System remains THE nonradioactive technology of,choice to label and ...
Other Biology Technology:Quantitation of the Protein MIA as a Marker for,Chondrocytes in Research Samples 2Quantitation of the Protein MIA as a Marker for,Chondrocytes in Research Samples 3Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 2Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 3Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 4The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 2The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 3The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 4The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 5Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... Expansion Kit - Monolayer Plus is a system ... as a monolayer in a serum-free environment. The ... Supplement, which has been optimized for neural stem ... (1996) Genes & Development 10 :3129). Human ...
... DNase is a preparation of deoxyribonuclease ... DNA to produce 3-hydroxyl oligonucleotides. This ... applications where maintaining the integrity of ... qualified for use with the Core ...
Biology Products:Biology NavigationMedical Navigation